A new Lancet study examines the potential for ‘microbubble-enhanced ultrasound,’ which helps therapeutics enter the brain ...

A groundbreaking nasal drop therapy is offering new hope for glioblastoma patients. This innovative treatment bypasses the ...

When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, Ph.D., the ...

For one of the most lethal brain cancers known, a simple nasal drop is emerging as an unexpectedly sophisticated weapon. Instead of relying on scalpels or high-dose chemotherapy, researchers are ...

Nasal drops may offer a new non-invasive way to help the body fight aggressive and deadly brain cancers. Researchers at ...

Hydralazine, a drug commonly used to treat high blood pressure and preeclampsia, may also help stop the growth of ...

Cordance Medical announced yesterday that it raised more than $8 million in an oversubscribed seed financing round.

A Penn-led team has revealed how hydralazine, one of the world's oldest blood pressure drugs and a mainstay treatment for ...

Phase 1 study in aggressive brain cancer (Glioblastoma) is the first clinical trial investigation of uTREAT®Site given green light by European Medicines Agency (EMA) and is now open for patient ...

Norman resident Mike Schuster is marking 10 years of survival after a glioblastoma diagnosis, crediting an Oklahoma ...

Nicole Schonlau is hoping the Huskers will recognize her husband's dedication to the team and to his family during this ...